[1] Naghma Khan, Farrukh Afaq, Mohammad Saleem, et al. Targeting Multiple Signaling Pathways by Green Tea Polyphenol(-)-Epigallocatechin-3-Gallate[J]. Cancer Res, 2006, 66(5): 2500-2505.
[2] Yang CS, Maliakal P, Meng X.Inhibition of carcinogenesis by tea[J]. Annu Rev Pharmacol Toxicol, 2002(42): 25-54.
[3] Yang CS, Sang S, Lambert JD, et al. Possible mechanisms of the cancer-preventive activities of green tea[J]. Molecular nutrition & food research, 2006, 50(2): 170-175.
[4] Park OJ, Surh YJ.Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies[J]. Toxicol Lett, 2004, 150(1): 43-56.
[5] Yang CS, Wang X, Lu G, et al. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance[J]. Nat Rev Cancer, 2009, 9(6): 429-439.
[6] Moyers SB, Kumar NB.Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr Rev 2004, 62(5):204-211.
[7] Yang CS, Landau JM, Huang MT, et al. Inhibition of carcinogenesis by dietary polyphenolic compounds[J]. Annual Review of Nutrition, 2001, 21: 381-406.
[8] Bettuzzi S, Brausi M, Rizzi F, et al. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia:a preliminary report from a one-year proof-of-principle study[J]. Cancer Res, 2006, 66(2): 1234-1240.
[9] Nagle DG, Ferreira D, Zhou YD.Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives[J]. Phytochemistry. 2006, 67(17): 1849-1855.
[10] Tachibana H, Koga K, Fujimura Y, et al. A receptor for green tea polyphenol EGCG[J]. Nat Struct Mol Biol, 2004, 11(4):380-381.
[11] Leone M, Zhai D, Sareth S, et al. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins[J]. Cancer Res, 2003, 63(23): 8118-8121.
[12] Ermakova S, Choi BY, Choi, et al. The intermediate filament protein vimentin is a new target for epigallocatechin gallate[J]. J Biol Chem, 2005, 208(17): 16882-16890.
[13] Katiyar SK, Afaq F, Azizuddin K, et al. Inhibition of UVB-induced oxidative stressmediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate[J]. Toxicol Appl Pharmacol, 2001, 176(2): 110-117.
[14] Maeda-Yamamoto M, Suzuki N, Sawai Y, et al. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells[J]. J agric Food Chem, 2003, 51(7): 1858-1863.
[15] Chung JY, Huang C, Meng X.Inhibition of activator protein 1 activity and cell growth by purified green tea polyphones and black tea polyphenols in H-ras-transformed cells:structure-activity relationship and mechanism involved[J]. Cancer Res, 1999, 59(18): 4610-4617.
[16] Hou Z, Lambert JD, Chin KV, et al. Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention[J]. Mutat Res, 2004,555(1/2): 3-19.
[17] Surh YJ, Chun KS, Cha HH. Molecular mechanisms underlying chemoprevention activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappaB activation[J]. Mutat Res, 2001, 480/481: 243-268.
[18] Dong Z, Ma W, Huang C, et al. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins[J]. Cancer Res, 1997, 57(19): 4414-4419.
[19] Huang C, Ma WY, Hanenberger D, et al. Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice[J]. J Biol Chem, 1997, 272(42): 26325-26331.
[20] Liang YC, Lin-Shiau SY, Chen CF, et al. Inhibition of cyclindependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate[J]. J Cell Biochem, 1999, 75(1): 1-12.
[21] Liang YC, Lin-Shiau SY, Chen CF, et al. Suppression of extracelluar signals and cell proliferation through EGF receptor binding epigallocatechin gallate in human A431 epidemloid carcinoma cells[J]. J Cell Biochem, 1997, 67(1): 55-65.
[22] Sah JF, Balasubramanian S, Eckert RL, et al. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases[J]. J Biol Chem, 2004, 279(13): 12755-12762.
[23] Masuda M, Suzui M, Lim JT, et al. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction[J]. J Exp Ther Oncol, 2002, 2(6): 350-359.
[24] Masuda M, Suzui M, Weinstein IB.Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines[J]. Clin Cancer Res, 2001, 7(12): 4220-4229.
[25] Shimizu M, Deguchi A, Lim JT, et al. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells[J]. Clin Cancer Res, 2005, 11(7): 2735-2746.
[26] Naasani I, Oh-Hara F, Oh-Hara T, et al. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo[J]. Cancer Res, 2003, 63(4): 824-830.
[27] Naasani I, Seimiya H, TsuruoT. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins[J]. Biochem Biophys Res Commun, 1998, 249(2): 391-396.
[28] Fang MZ, Wang Y, Ai N, et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines[J]. Cancer Res, 2003, 63(22): 7563-7570.
[29] Navarro-Perán E, Cabezas-Herrera J, García-Cánovas F, et al. The antifolate activity of tea catechins[J]. Cancer Res, 2005, 65(6): 2059-2064.
[30] Montagut C, Rovira A, Albanell J.The proteasome: anovel target for anticancer therapy[J]. Clin Transl Oncol, 2006, 8(5):313-317.
[31] Nam S, Smith DM, Dou QP.Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo[J]. J Biol Chem, 2001, 276(16): 13322-13330.
[32] Li M, He Z, Ermakova S,et al. Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation[J]. Cancer Epidemiol Biomarkers Prev, 2007, 16(3): 598-605.
[33] He ZW, Tang F, Ermakova S,et al. Fyn is a novel target of (-)-epigallocatechin gallate in the inhibition of JB6 C141 cell transformation[J]. Moi Carcinog, 2008, 47(2): 172-183.
[34] Ermakova SP, Bong SK, Bu YC, et al. (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78[J]. Cancer Res, 2006, 66(18): 9260-9269.
[35] Shim JH, Choi HS, Pugliese A, et al. (-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase[J]. J Biol Chem, 2008, 283(42): 28370-28379.
[36] Konstantinopoulos PA, Karamouzis MV, Papatsoris AG, et al. Matrix metalloproteinase inhibitors as anticancer agents[J]. Int J Biochem Cell, 2008, 40(6/7): 1156-1168.
[37] Zhen MC, Huang XH, Wang Q, et al. Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation[J]. Acta Pharmacol Sin, 2006, 27(12): 1600-1607.
[38] Fassina G, Vene R, Morini M, et al. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate[J]. Clin Cancer Res, 2004, 10(14): 4865-4873.
[39] Ho YC, Yang SF, Peng CY, et al. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator[J]. J Oral Pathol Med, 2007, 36(10): 588-593.
[40] Berger S J, Gupta S, Belfi CA, et al. Green tea constituent (-)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells[J]. Biochem Biophys Res Commun, 2001, 288(1): 101-105.
[41] Hayakawa S, Saeki K, Sazuka M, et al. Apoptosis induction by epigallocatechin gallate involves its binding to Fas[J]. Biochem Biophys Res Commun, 2001, 285(5): 1102-1106.
[42] Brusselmans K, De Schrijver E, Heyns W, et al. Epigallo-catechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells[J]. Int J Cancer.2003, 106(6): 856-862.
[43] Jung YD, Kim MS, Shin BA, et al. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells[J]. Br J Cancer, 2001, 84(6): 844-850.
[44] Jankun J, Selman SH, Swiercz R, et al. Why drinking green tea could prevent cancer[J]. Nature, 1997, 387(6633): 561.
[45] Yoshizawa S, Horiuchi T, Fujiki H, et al. Antitumor promoting activity of(-)-epigallocatechin gallate, the main constituent of “tannin” in green tea[J]. Phytother Res, 1987(1): 44-47.
[46] Gupta S, Hastak K, Ahmad N, et al. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols[J]. Proc Natl Acad Sci USA, 2001, 98(18): 10350-10355.
[47] AdhamiVM, Siddiqui IA, AhmadN, et al. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer[J]. Cancer Res, 2004, 64(23): 8715-8722.
[48] Vayalil PK, Elmets CA, Katiyar SK.Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin[J]. Carcinogenesis, 2003 24(5): 927-936.
[49] Liao J, Yang GY, Park ES, et al. Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea[J]. Nutr Cancer, 2004, 48(1): 44-53.
[50] Ju J, Hong J, Zhou JN, et al. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by(-)-epigallocatechin-3-
1)gallate, the major catechin in green tea[J]. Cancer Res, 2005, 65(22): 10623-10631.
[51] Umeda D, Yano S, Yamada K, et al. Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor[J]. J BiolChem, 2008, 283(6): 3050-3058.
[52] Ahn WS, Yoo J, Huh SW, et al. Protective effects of green tea extract (polyphenon E and EGCG) on human cervical lesions[J]. Eur J Cancer Prev, 2003(12): 383-390.
[53] Jatoi A, Ellison N, Burch PA, et al. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma[J]. Cancer, 2003, 97(6): 1442-1446.
[54] Fujiki H.Two stages of cancer prevention with green tea[J]. J Cancer Res Clin Oncol, 1999, 125(11): 589-597.
[55] Lee WJ, Shim JY, Zhu BT, et al. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids[J]. Mol.Pharmacol, 2005, 68(4): 1018-1030.
[56] Abe I, Seki T, Umehara K, et al. Green tea polyphenols: novel and potent inhibitors of squalene epoxidase[J]. Biochem Biophys Res Commun, 2000, 268(3): 767-771.
[57] Lamy S, Gingras D, Beliveau R.Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation[J]. Cancer Res, 2002, 62(2): 381-385.
[58] U Ullmann, J Haller, JP Decourt, et al. A single ascending dose study of EGCg in healthy volunteers[J]. J Int Met Res, 2003, 31(2): 88-101.
[59] RA Isbrucker, JA Edwards, E Wolz, et al. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: Teratogenicity and reproductive toxicity studies in rats[J]. Food and Chemical Toxicology, 2006, 44(5): 651-661.
[60] Chung S Y, Joshua DL, Zhe H, et al. Molecular Targets for the Cancer Preventive Activity of Tea Polyphenols[J]. Molecular Carcinogenesis, 2006, 45(6): 431-435.
[61] Li L,Chan TH.Enantioselective synthesis of EGCG, the active polyphenol component from green tea[J]. Org Lett, 2001, 3(5): 739-741.
[62] Surh YJ.Cancer chemoprevention with dietary phytochemicals[J]. Nature Reviews Cancer, 2003, 3(10): 768-780.
[63] Pisters KM, Newman RA, Coldman B, et al. Phase I trial of oral green tea extract in adult patients with solid tumors[J]. J Clin Oncol, 2001, 19(6): 1830-1838.
[64] Shanafelt T D, Call T, Zent C S, et al. Phase I trial of daily oral polyphenon E in patients with asymptomatic rai stage 0 to II chronic lymphocytic leukemia[J]. Journal of clinical oncology, 2009, 27(23): 3808-3814.
[65] Shanafelt T D, Call T, Zent C S, et al. Phase II trial of daily, oral green tea extract in patients with asymptomatic, Rai stage 0-II chronic lymphocytic leukemia (CLL)[J]. Journal of Clinical Oncology, 2010, 28(15-suppl): 6522.
[66] Joshua D Lambert, Shengmin Sang, Chung S Yang.Possible controversy over dietary polyphenols: benefits vs risks[J]. Chem Res Toxicol, 2007, 20(4): 583-585.
[67] Yang CS, Lambert JD, Sang S.Antioxidative and anti-carcinogenic activities of tea polyphenols[J]. Arch Toxicol, 2009, 83(1): 11-21.
浙公网安备 33019902000101号 
